8-K: Surgery Partners Appoints Justin Oppenheimer COO

Surgery Partners, Inc. announced the appointment of Justin Oppenheimer as Chief Operating Officer and National Group President, effective January 1, 2026.

Summary

• Surgery Partners, Inc. has appointed Justin Oppenheimer as its new Chief Operating Officer and National Group President, effective January 1, 2026.
• Mr. Oppenheimer, 41, brings a decade of leadership experience from the Hospital for Special Surgery (HSS), where he served as Chief Strategy Officer and Chief Operating Officer.
• His compensation package includes an annual base salary of $660,000.
• He will receive a $500,000 cash signing bonus within 30 days of his employment commencement.
• Mr. Oppenheimer is eligible for an annual target bonus of 100% of his base salary, based on performance goals.
• He will also receive an initial restricted stock award of $1,250,000, vesting on its first anniversary, and will be eligible for annual equity grants with a target of $1,500,000 starting in 2026.
• The employment agreement includes standard benefits, 20 days of vacation, and provisions for severance, restrictive covenants (non-compete, non-solicitation, non-disparagement), and confidentiality.

Sentiment

Score: 7

Explanation: The appointment of a highly experienced COO and National Group President is a positive strategic move for the company, indicating a focus on operational strength and national expansion. The compensation package is competitive, aligning executive incentives with company performance. No negative financial or operational news was disclosed.

Positives

• Appointment of a highly experienced executive, Justin Oppenheimer, with a decade of leadership experience from a prominent institution (Hospital for Special Surgery).
• Mr. Oppenheimer's background as Chief Strategy Officer and Chief Operating Officer at HSS suggests strong strategic and operational capabilities.
• The new role as National Group President indicates a focus on expanding and optimizing the company's national operations.
• The comprehensive compensation package, including a significant base salary, signing bonus, and substantial equity grants, is competitive and designed to attract top talent.

Negatives

• The significant compensation package for the new COO will increase executive compensation expenses.

Risks

• The $500,000 signing bonus is repayable if the Executive resigns without Good Reason or is terminated for Cause before the first anniversary of the Commencement Date, posing a potential financial risk to the Executive.
• The enforceability and scope of the restrictive covenants (non-compete, non-solicitation) could be challenged, potentially impacting the company's ability to protect its business interests if the Executive departs.
• The non-compete clause has geographical limitations (50-mile radius of Nashville or active business areas) and exceptions for certain non-competitive activities or entities with limited competitive revenue, which might not fully protect the company's broader interests.
• The company is exposed to the risk of losing key talent if the Executive terminates employment for "Good Reason" or is terminated "without Cause," triggering substantial severance payments.

Future Outlook

The appointment of a new Chief Operating Officer and National Group President suggests a strategic focus on operational efficiency and national growth for Surgery Partners. The compensation structure, including performance-based bonuses and annual equity grants, aligns the executive's incentives with the company's long-term performance and shareholder value creation.

Management Comments

• The company has duly caused this report to be signed on its behalf by David T. Doherty, Executive Vice President, Chief Financial Officer.
• Eric Evans, Chief Executive Officer, signed the employment agreement on behalf of Surgery Partners, Inc.

Industry Context

The appointment of a seasoned COO and National Group President from a major hospital system like HSS indicates Surgery Partners' commitment to strengthening its leadership in the competitive healthcare services sector, particularly in ambulatory surgery centers and physician-owned surgical hospitals. This move could signal an intent to enhance operational scale, integrate services more effectively, and potentially expand market presence across the United States, aligning with broader trends of consolidation and efficiency drives in healthcare.

Comparison to Industry Standards

• The compensation package for a COO and National Group President in the healthcare services industry, particularly for a publicly traded company like Surgery Partners, appears competitive, though specific benchmarks for comparable companies are not provided in the filing.
• The inclusion of a significant signing bonus, performance-based annual bonus, and substantial equity grants is a common practice to attract and retain high-caliber executives in this sector.
• The restrictive covenants, including non-compete and non-solicitation clauses, are standard in executive employment agreements within the healthcare industry to protect proprietary information and business relationships.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The appointment of a new COO and National Group President with extensive experience could be viewed positively, potentially leading to improved operational efficiency and strategic growth, which may enhance shareholder value.
• Employees: The addition of a new senior executive may bring new leadership perspectives and strategic direction, potentially impacting organizational structure and operational processes.
• Customers/Patients: A focus on operational leadership could lead to improved service delivery and patient experience across the company's facilities.
• Suppliers/Creditors: No direct impact is immediately apparent, but improved operational performance could indirectly strengthen the company's financial health and relationships with these stakeholders.

Next Steps

• Justin Oppenheimer will officially commence his employment as Chief Operating Officer and National Group President on January 1, 2026.
• The company will provide Mr. Oppenheimer with a $500,000 cash payment within 30 days after his Commencement Date.
• Mr. Oppenheimer will be eligible for annual equity grants under the 2025 Omnibus Incentive Plan, with a target of $1,500,000, commencing in calendar year 2026.
• An initial restricted stock award of $1,250,000 will be granted to Mr. Oppenheimer as soon as reasonably practicable following the Commencement Date, vesting on its first anniversary.

Key Dates

Recommendation

The appointment of a new COO is a positive development, bringing experienced leadership to Surgery Partners. However, this is an executive change rather than a direct financial performance update. While it signals strategic intent for operational improvement and growth, it does not immediately alter the company's financial outlook or competitive position to warrant a "buy" or "sell" recommendation based solely on this filing. Investors should "hold" and monitor future operational results and strategic execution under the new leadership.

Keywords

Surgery Partners, SGRY, Justin Oppenheimer, Chief Operating Officer, National Group President, Executive Appointment, Healthcare Management, Ambulatory Surgery Centers, Hospital for Special Surgery, Executive Compensation, Employment Agreement, Corporate Governance, SEC Filing